Salix Coronary Plaque vs HeartFlow Analysis
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if your primary need is rapid, near real-time assessment of coronary artery plaque and stenosis directly from CCTA scans at the point of care. This tool is ideal for quickly identifying and quantifying plaque burden, including high-risk features and calcium scoring, to aid in immediate diagnostic decisions.
View Salix Coronary Plaque →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a comprehensive, non-invasive functional assessment of coronary artery disease, including the hemodynamic significance of stenoses. This tool excels in creating personalized 3D models and performing FFRct analysis to simulate blood flow, providing crucial insights for guiding treatment strategies and avoiding unnecessary invasive procedures.
View HeartFlow Analysis →For a physician evaluating AI tools for coronary artery disease, Salix Coronary Plaque and HeartFlow Analysis offer distinct approaches. Salix focuses on near real-time, point-of-care assessment of coronary artery plaque and stenosis directly from CCTA scans. It excels at rapidly quantifying plaque, identifying high-risk features like low-attenuation plaque, and assessing stenosis, providing an editable automated report. This tool is best suited for practices prioritizing immediate, detailed plaque characterization and stenosis assessment at the point of care.
In contrast, HeartFlow Analysis provides a more comprehensive, non-invasive diagnostic solution by creating personalized 3D models of coronary arteries from CT scans. Its key differentiator is the inclusion of Fractional Flow Reserve derived from CT (FFRct) analysis, which simulates blood flow to assess the functional significance of blockages, alongside plaque quantification and characterization. HeartFlow is ideal for physicians seeking a deeper understanding of both anatomical and functional aspects of CAD, particularly when considering the need for invasive procedures. The practical difference lies in Salix’s emphasis on rapid, direct plaque and stenosis assessment, versus HeartFlow’s integration of functional FFRct analysis for a more holistic diagnostic picture.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | HeartFlow Analysis |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor for pricing |
| Deployment | Cloud | Cloud-based (AWS) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Salix Coronary PlaqueSalix Coronary Plaque emphasizes a web-based, near real-time, point-of-care assessment with integrated workflow management and automated report generation, designed for rapid clinician use without external reading teams. This focus on immediate, in-house processing suggests a higher degree of usability and workflow efficiency compared to HeartFlow's process, which involves uploading images to a cloud service for analysis by a team of analysts, potentially taking longer.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis offers Fractional Flow Reserve derived from CT (FFRct) analysis, a non-invasive physiological assessment of coronary blood flow using computational fluid dynamics, which provides a critical functional dimension to anatomical information. This technology has demonstrated high diagnostic accuracy and prognostic power in large real-world studies, leading to improved diagnostic decision-making and patient outcomes. While Salix focuses on comprehensive plaque characterization, FFRct provides a more advanced and clinically validated measure of lesion significance.
Pricing & Value
HeartFlow AnalysisBoth tools have established CPT codes and reimbursement pathways, indicating a strong value proposition for providers. However, HeartFlow Analysis explicitly states coverage by Medicare and most U.S. commercial payers for both FFRct and AI-enabled quantitative plaque analysis, and has multiple Category I CPT codes, suggesting broader and more established financial pathways for adoption.
Enterprise Readiness
HeartFlow AnalysisHeartFlow Analysis explicitly states in its structured facts that it 'has_baa: yes' and is 'hipaa_compliant: yes'. While Artrya Salix Coronary Plaque is also cloud-based and web searches confirm its HIPAA compliance and ISO certifications, HeartFlow's direct and explicit statements in the primary data provide immediate and clear assurance for enterprise-level contractual and regulatory requirements.
Innovation
HeartFlow AnalysisHeartFlow Analysis's pioneering use of Computational Fluid Dynamics (CFD) to non-invasively derive Fractional Flow Reserve from CT (FFRct) represents a more significant and transformative innovation. This technology provides a unique physiological assessment of coronary artery disease that was previously only available through invasive procedures, offering a deeper understanding of blood flow limitations beyond anatomical plaque features.
Support & Docs
HeartFlow AnalysisHeartFlow Analysis provides a comprehensive support program that includes hands-on training, technology integration, expert coding and reimbursement support, peer mentorship, and educational materials. This detailed offering indicates a robust commitment to assisting customers with implementation, optimization, and ongoing use, which is more extensive than the general availability of a user guide for Salix Coronary Plaque.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | HeartFlow Analysis |
|---|---|---|
| Product Name | Salix Coronary Plaque | HeartFlow Analysis |
| Company | Artrya Limited | HeartFlow |
| Primary Function | AI-driven, web-based software for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans. | Software and AI delivering a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. |
| Key Feature: Plaque Analysis | Detection and quantification of coronary plaque (atherosclerosis), Identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), Quantification of calcifications (calcium scoring). | Plaque Analysis (quantification and characterization). |
| Key Feature: Blood Flow/Stenosis Assessment | Stenosis assessment. | Fractional Flow Reserve derived from CT (FFRct) analysis, Computational Fluid Dynamics (CFD) for blood flow simulation. |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and HeartFlow Analysis.